D. E. Shaw & Co., Inc. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,775,025
-53.3%
357,146
-41.8%
0.00%
-50.0%
Q2 2023$5,938,806
+7.2%
613,513
+21.4%
0.01%0.0%
Q1 2023$5,537,584
+1106.1%
505,254
+375.4%
0.01%
+500.0%
Q4 2022$459,147
-38.9%
106,284
+6.5%
0.00%0.0%
Q3 2022$751,000
-34.2%
99,837
-12.1%
0.00%0.0%
Q2 2022$1,141,000
+16.8%
113,560
+43.9%
0.00%0.0%
Q1 2022$977,000
-77.3%
78,913
-58.1%
0.00%
-75.0%
Q4 2021$4,307,000
-41.7%
188,333
-43.6%
0.00%
-42.9%
Q3 2021$7,389,000
+1340.4%
333,869
+742.9%
0.01%
Q2 2021$513,000
+233.1%
39,611
+234.7%
0.00%
Q1 2021$154,000
-96.3%
11,835
-96.1%
0.00%
-100.0%
Q4 2020$4,158,000
-16.7%
301,033
-11.2%
0.00%
-20.0%
Q3 2020$4,992,000
+162.9%
339,039
+189.9%
0.01%
+150.0%
Q2 2020$1,899,000
+6.7%
116,966
-4.6%
0.00%
-33.3%
Q1 2020$1,779,000
-0.6%
122,638
-63.4%
0.00%
+50.0%
Q3 2019$1,789,000
-30.9%
335,027
-14.8%
0.00%
-33.3%
Q2 2019$2,588,000
-27.4%
393,300
-28.3%
0.00%
-40.0%
Q1 2019$3,564,000
+34.4%
548,198
+41.0%
0.01%
+25.0%
Q4 2018$2,652,000
+51.4%
388,811
+47.3%
0.00%
+100.0%
Q3 2018$1,752,000
+169.5%
263,871
+128.5%
0.00%
+100.0%
Q2 2018$650,000
-46.1%
115,472
-50.4%
0.00%
-50.0%
Q1 2018$1,207,000232,6330.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders